|
Pharma
returning to prominence on back of competitive strength
The Indian pharmaceutical industry has weathered many a cross
current on the basis of strong fundamentals. Today, investors
once lured to other sectors, are returning to the pharma industry
on the basis of its competitive strengths.
Changing
Indian pharma's contribution to global health
Gaining a clear vision of the Indian pharmaceutical industry
in 2020 depends on the industry's 20/20 eyesight in the present.
God
is in the details: Stitching loose ends for realising the
vision
India and China continue to fascinate the worldthe two
ancient civilisations are today the world's fastest growing
economies and predicted to dominate global economy over the
next few decades.
Imperatives
for the Indian pharmaceutical industry in a changing world
The Indian pharmaceutical industry can look forward to the
New Year, as well as to the years to come, with great expectations.
'It
is important to create the right environment for building
entrepreneurship'
India, today is emerging as a market of great opportunity
for the global pharmaceutical industry. The pharma industry
has evolved dynamically with India joining the WTO and the
implementation of product patents.
'Indian
pharma is undergoing a radical makeover'
The roots of the pharmaceutical industry were laid centuries
back. It had basic applications of curing diseases and treating
wounds.
'Innovation-driven
semi-blockbusters will emerge'
The pharmaceutical industry is a prisoner of past success.
While the business environment has changed dramatically in
the past five years, the business model that served the industry
well in the past has not kept pace.
India
to be amongst top three generic makers in the world
By 2020, global integration of most sectors in the world economy
would be much more pronounced, and the pharma industry will
not be an exception.
India
will emerge as a dominant force on the global arena
The pharmaceutical industry in India has made phenomenal progress
in the past 10 years.
'Industry
needs to focus more on R&D and better productivity'
India is likely to be in the league of top 10 pharmaceutical
markets by 2020.
|